TABLE 2.
Statin therapy at baseline (n=837)
| Total daily statin dose, n (%)
|
|||||
|---|---|---|---|---|---|
| Statin | Patients, n (%) | 10 mg | 20 mg | 40 mg | 80 mg |
| Atorvastatin | 423 (50.5) | 105 (12.5) | 154 (18.4) | 117 (14.0) | 41 (4.9) |
| Simvastatin | 167 (20.0) | 20 (2.4) | 58 (6.9) | 67 (8.0) | 14 (1.7) |
| Rosuvastatin | 119 (14.2) | 62 (7.3) | 38 (4.5) | 17 (2.0) | 0 |
| Pravastatin | 103 (12.3) | 6 (0.7) | 39 (4.7) | 56 (6.7) | 2 (0.2)* |
| Lovastatin | 27 (3.2) | 3 (0.4) | 12 (1.4) | 12 (1.4) | 0 |
| Fluvastatin | 9 (1.1) | 0 | 5 (0.6) | 4 (0.5) | 0 |
| Total | 195 (23.3) | 305 (36.4) | 273 (32.6) | 57 (6.8) | |
Four subjects had missing data regarding their statin use; 21 patients reported taking more than one statin; one subject reported taking 15 mg/day of atorvastatin; six subjects reported taking 30 mg/day of a statin; nine subjects reported taking 60 mg/day of a statin.
*
Both subjects reported taking 80 mg/day of pravastatin even though the recommended maximum dose is 40 mg/day